A pan-cancer analysis leveraging data from TCGA revealed that, in contrast to normal tissues, mRNA expression levels of METTL3 are significantly upregulated in tumor tissues, whereas the expression levels of METTL14 remain unchanged (Fig. S1). This evidence concerns the gene METTL3 and cancer.